As shown in Fig. 4d–m, the AUCs for early-stage cancer detection ranged from 0.68 to 0.80, which is similar to the all-stage cancer detection for the corresponding cancer type, indicating that plasma of CS-CD44 could be a promising biomarker for early detection. The gene discussed is CD44; the disease is cancer.